ANTEOTECH LTD — Capital/Financing Update 2016

Mar 2, 2016

Appendix 3B

New issue announcement,

application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12

Name of entity Anteo Diagnostics Limited ABN 75 070 028 625

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1 +Class of+securities issued or to be issued 2 Number of+securities issued or to be issued (if known) or maximum number which may be issued	Ordinary fully paid shares (Ordinary Shares) Unlisted options over Ordinary Shares (Options) Convertible Securities(Convertible Securities)
	7,500,000 Fully paid Ordinary Shares (Collateral Shares) 4,649,156 Fully paid Ordinary Shares (Commencement Fee Shares) 9,800,000 Options 1,780,000 Convertible Securities with a face value of US$1.00 per Convertible Securities.

• See chapter 19 for defined terms.

Appendix 3B Page 1

01/08/2012

• 3 Principal terms of the[+] securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

• 12,149,156 Fully paid ordinary shares

Options 9,800,000 Exercise Price: $0.089 Expiry: 3 years from date of issue.

The Options will not be quoted. On exercise of the Options, the Ordinary Shares issued will rank pari passu with existing Ordinary Shares.

Convertible Securities

• The face value of each Convertible Security is US$1.00 and the aggregate face value of all the Convertible Securities is US$1,780,000 (the Principal Amount ).

• The Convertible Securities do not bear interest.

• The Convertible Securities shall be convertible into new Ordinary Shares of the Company determined by dividing the Principal Amount by the lesser of: (a) 92% of the average of the five daily VWAPs per share during a specified period prior to the conversion date of the Convertible Security; or (b) 140% of the average of the daily VWAPs per share during the 20 trading days prior to 2[nd] March 2016.

• The Ordinary Shares issued upon conversion of the Convertible Securities will rank pari passu with existing Ordinary Shares.

• The Convertible Securities do not carry any voting rights at meetings of shareholders of the Company, and have no rights of participation in any rights issues undertaken by the Company prior to their conversion.

4 Do the+securities rank equally in all respects from the date of allotment with an existing+class of quoted+securities? If the additional securities do not rank equally, please state:  the date from which they do  the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment  the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 5 Issue price or consideration 6 Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets)	The Ordinary Shares rank_pari passu_with existing Ordinary Shares. The Options will not be quoted. On exercise of the Options, the Ordinary Shares issued will rank_pari passu_with existing Ordinary Shares. On conversion of the Convertible Securities, the Ordinary Shares will rank_pari passu_with existing Ordinary Shares.
	4,649,156 Commencement Fee Shares (issued at a deemed price of $0.059) 7,500,000 Collateral Shares are issued for nil consideration, and have been issued as collateral shares as outlined in the ASX announcement dated 3 March 2016. Options are issued for nil consideration. US$1,500,000 for the Convertible Securities (face value US$1,780,000).
	The Ordinary Shares and Options were issued to secure the Convertible Securities Subscription Agreement, details of which were announced to the market on 3 March 2016. The purpose of the issue of the Convertible Securities is to raise capital for general corporate and working capital purposes.

6a Is the entity an+eligible entity that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b – 6h in relation to the+securities the subject of this Appendix 3B, and comply with section 6i 6b The date the security holder resolution under rule 7.1A was passed	Yes
	9 November 2015

• See chapter 19 for defined terms.

Appendix 3B Page 3

01/08/2012

6c Number of +securities issued without security holder approval under rule 7.1 6d Number of+securities issued with security holder approval under rule 7.1A 6e Number of+securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting) 6f Number of securities issued under an exception in rule 7.2 6g If securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the issue date and both values. Include the source of the VWAP calculation. 6h If securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements 6i Calculate the entity’s remaining issue capacity under rule 7.1 and rule 7.1A – complete Annexure 1 and release to ASX Market Announcements 7 Dates of entering+securities into uncertificated holdings or despatch of certificates 8 Number and +class of all +securities quoted on ASX (_including_the securities in section 2 if applicable)	12,149,156 Fully Paid Ordinary Shares 9,800,000 Unlisted Options 1,780,000 Convertible Securities	12,149,156 Fully Paid Ordinary Shares 9,800,000 Unlisted Options 1,780,000 Convertible Securities
	Nil
	N/A
	Nil
	N/A
	N/A
	Refer Annexure 1
	3 March 2016
	Number	+Class
	1,031,521,735	Fully Paid Ordinary Shares

• See chapter 19 for defined terms.

Appendix 3B Page 5

01/08/2012

9 Number and +class of all +securities not quoted on ASX (_including_the securities in section 2 if applicable)	9,700,000 9,000,000 4,000,000 1,900,000 17,000,000 1,000,000 1,000,000 1,200,000 9,800,000 US$1,780,000	12.0c options expiring 15/8/2017 12.0c options expiring 31/10/2017 12.0c options expiring 15/12/2018 13.5c options expiring 16/4/2019 20c options expiring 10/11/2018 20.0c options expiring 15/12/2018 25.0c options expiring 24/2/2018 26.5c options expiring 16/4/2018 8.9c options expiring 3/3/2019 Convertible Securities with a face value of US$1.00 each

10 Dividend policy (in the case of a N/A trust, distribution policy) on the increased capital (interests)

Part 2 - Bonus issue or pro rata issue

11 Is security holder approval required? 12 Is the issue renounceable or non- renounceable? 13 Ratio in which the+securities will be offered 14 +Class of+securities to which the offer relates 15 +Record date to determine entitlements 16 Will holdings on different registers (or subregisters) be aggregated for calculating entitlements? 17 Policy for deciding entitlements in relation to fractions 18 Names of countries in which the entity has+security holders who will not be sent new issue documents Note: Security holders must be told how their entitlements are to be dealt with. Cross reference: rule 7.7. 19 Closing date for receipt of acceptances or renunciations	Not Applicable
	Not Applicable
	Not Applicable
	Not Applicable
	Not Applicable
	Not Applicable
	Not Applicable
	Not Applicable
	Not Applicable

• See chapter 19 for defined terms.

Appendix 3B Page 7

01/08/2012

20 Names of any underwriters 21 Amount of any underwriting fee or commission 22 Names of any brokers to the issue 23 Fee or commission payable to the broker to the issue 24 Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of+security holders 25 If the issue is contingent on +security holders’ approval, the date of the meeting 26 Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent to persons entitled 27 If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders 28 Date rights trading will begin (if applicable) 29 Date rights trading will end (if applicable) 30 How do+security holders sell their entitlements_in full_through a broker? 31 How do+security holders sell_part_ of their entitlements through a broker and accept for the balance? 32 How do+security holders dispose of their entitlements (except by sale through a broker)?	Not Applicable
	Not Applicable
	Not Applicable
	Not Applicable
	Not Applicable
	Not Applicable
	Not Applicable
	Not Applicable
	Not Applicable
	Not Applicable
	Not Applicable
	Not Applicable
	Not Applicable

• See chapter 19 for defined terms.

Appendix 3B Page 8

01/08/2012

• 33 +Despatch date

Not Applicable

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

• 34 Type of securities ( tick one )

• (a) X Securities described in Part 1

• (b) All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

• 35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders

• 36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories 1 - 1,000

• 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over

• 37 A copy of any trust deed for the additional[+] securities

• See chapter 19 for defined terms.

Appendix 3B Page 9

01/08/2012

Entities that have ticked box 34(b)

38 Number of securities for which +quotation is sought 39 Class of +securities for which quotation is sought 40 Do the+securities rank equally in all respects from the date of allotment with an existing+class of quoted +securities? If the additional securities do not rank equally, please state:  the date from which they do  the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment  the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 41 Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another security, clearly identify that other security) 42 Number and+class of all+securities quoted on ASX (_including_the securities in clause 38)	Not Applicable
	Not Applicable
	Not Applicable
	Not Applicable
	Not Applicable	Not Applicable

• See chapter 19 for defined terms.

Appendix 3B Page 10

01/08/2012

Quotation agreement

• 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

• 2 We warrant the following to ASX.

• The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

• There is no reason why those[+] securities should not be granted[+] quotation.

• An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

• Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

• If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

• 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

• 4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before[+] quotation of the[+] securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: Shane Hartwig (Company secretary)

Date: ....3 March 2016

• See chapter 19 for defined terms.

Appendix 3B Page 11

01/08/2012

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for[+] eligible entities

Introduced 01/08/12

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

Part 1	Part 1
Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement capacity is calculated
Insertnumber of fully paid ordinary securities on issue 12 months before date of issue or agreement to issue	857,314,493
Addthe following: • Number of fully paid ordinary securities issued in that 12 month period under an exception in rule 7.2 • Number of fully paid ordinary securities issued in that 12 month period with shareholder approval • Number of partly paid ordinary securities that became fully paid in that 12 month period Note: • Include only ordinary securities here – other classes of equity securities cannot be added • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed • It may be useful to set out issues of securities on different dates as separate line items	70,092,623 Entitlement Offer Acceptances 70,954,330 Shortfall Entitlement Shares 9,222,909 Shortfall Entitlement Shares 9,789,733 DIAsource Shares
Subtractthe number of fully paid ordinary securities cancelled during that 12 month period	nil
“A”	1,017,374,088

• See chapter 19 for defined terms.

Appendix 3B Page 12

01/08/2012

Step 2: Calculate 15% of “A”

Step 2: Calculate 15% of “A”	Step 2: Calculate 15% of “A”
“B”	0.15 [Note: this value cannot be changed]
Multiply“A” by 0.15	152,606,113
Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already been used
Insertnumber of equity securities issued or agreed to be issued in that 12 month period not counting_those issued: • Under an exception in rule 7.2 • Under rule 7.1A • With security holder approval under rule 7.1 or rule 7.4 _Note: • This applies to equity securities, unless specifically excluded – not just ordinary securities • Include here (if applicable ) the securities the subject of the Appendix 3B to which this form is annexed • It may be useful to set out issues of securities on different dates as separate line items	1,998,491 7,500,000 Collateral Shares 4,649,156 Commencement Fee Shares 9,800,000 Unlisted options 1,780,000 Convertible Securities -Assuming a conversion date of 2nd March 2016, these Convertible Securities would convert into 42,438,446 Fully Paid Ordinary Shares
“C”	66,386,093
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1
“A” x 0.15 Note: number must be same as shown in Step 2	152,606,113
Subtract“C” Note: number must be same as shown in Step 3	66,386,093
Total[“A” x 0.15] – “C”	86,220,020

that has already been used
Insertnumber of equity securities issued or	1,998,491
agreed to be issued in that 12 month period
_not counting_those issued:	7,500,000 Collateral Shares
• Under an exception in rule 7.2	4,649,156 Commencement Fee Shares
• Under rule 7.1A	9,800,000 Unlisted options
• With security holder approval under rule 7.1 or rule 7.4	1,780,000 Convertible Securities -Assuming a conversion date of 2nd March 2016, these
Note:	Convertible Securities would convert into
• This applies to equity securities, unless	42,438,446 Fully Paid Ordinary Shares
specifically excluded – not just ordinary
securities
• Include here (if applicable ) the
securities the subject of the Appendix
3B to which this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
“C”	66,386,093
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1

Step 4: Subtract “C” from [“A” x “B”] to calculate remaining	Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15	152,606,113
Note: number must be same as shown in
Step 2
Subtract“C”	66,386,093
Note: number must be same as shown in
Step 3
Total[“A” x 0.15] – “C”	86,220,020

• See chapter 19 for defined terms.

Appendix 3B Page 13

01/08/2012

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

1,017,374,088 “A” Note: number must be same as shown in Step 1 of Part 1

Step 2: Calculate 10% of “A”

“D” 0.10 Note: this value cannot be changed 101,737,409 Multiply “A” by 0.10

Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used

Insert number of equity securities issued or nil agreed to be issued in that 12 month period under rule 7.1A

Notes:

• This applies to equity securities – not just ordinary securities

• Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed

• Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

• It may be useful to set out issues of securities on different dates as separate line items

“E” nil

• See chapter 19 for defined terms.

Appendix 3B Page 14

01/08/2012

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A	Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A
“A” x 0.10 Note: number must be same as shown in Step 2	101,737,409
Subtract“E” Note: number must be same as shown in Step 3	nil
Total[“A” x 0.10] – “E”	101,737,409

• See chapter 19 for defined terms.

Appendix 3B Page 15

01/08/2012